Copyright: © 2016 Elsevier Ltd. All rights reserved.

June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative ...

Pioneering small-molecule program, NT-0796, targets chronic inflammation and its fundamental role in the complex cycle of weight regulation Oral, brain-penetrant NLRP3 inflammasome inhibitor being ...

Products Market Alerts MyCollection Price Database Become a Partner Gallery ...

The Company’s PALISADE-3 Phase 3 clinical trial remains on track for expected topline data in the fourth quarter of this year. Topline results for its PALISADE-4 Phase 3 clinical trial are ...

and NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 VERITAC-2 clinical trial (NCT05654623 ...

COLUMBIA, S.C. (AP) — Dr. Annie Andrews, the South Carolina Democrat who unsuccessfully challenged Rep. Nancy Mace in 2022, says she’s running against Republican Sen. Lindsey Graham in 2026 ...

Annie Patnode, 34, of Bemidji, MN passed away unexpectedly on Thursday, May 22, 2025 in her home. Visitation will be 5:00-7:00 p.m., Wednesday, May 28, 2025 at St. Philip’s Catholic Church with ...

A patient participating in the Phase 2 pivotal trial of RP-A501 experienced an unexpected Serious Adverse Event (SAE). The SAE involved clinical complications related to a capillary leak syndrome.

A patient participating in the Phase 2 pivotal trial of RP-A501 experienced an unexpected Serious Adverse Event (SAE). The SAE involved clinical complications related to a capillary leak syndrome.

Helldivers 2's latest major order is the "final phase" of the battle for the divers' home planet that's been raging since the Heart of Democracy update dropped on May 20. First of all, the last ...